Norris Perne & French’s ResMed RMD Stock Holding History

Norris Perne & French’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4,800	Closed	-$225K	–	176
2013 Q4	$225K	Buy	+4,800	New	+$243K	0.04%	182

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Norris Perne & French's RMD Position: Q1 2014 in Review

Norris Perne & French sold out of ResMed (RMD) in Q1 2014, closing a stake of 4,800 shares — an estimated $225K sold.

Norris Perne & French first reported a position in RMD in Q4 2013 and held it in 1 quarter. The position peaked at $225K in Q4 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

Norris Perne & French reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
Norris Perne & French sold 4,800 ResMed shares in Q1 2014, an estimated $225K.
Norris Perne & French first reported a position in ResMed in Q4 2013 and held it in 1 quarter.
Norris Perne & French's ResMed position peaked at $225K in Q4 2013.
318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Norris Perne & French's 13F filing for Q1 2014, filed 14 Apr 2014.